Journal article
Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial
Abstract
The role of rivaroxaban in the treatment of leg superficial venous thrombosis (SVT) is uncertain. This article aims to determine if rivaroxaban is an effective and safe treatment for leg SVT. Patients with symptomatic leg SVT of at least 5 cm length were randomized to 45 days of rivaroxaban 10 mg daily or to placebo, and followed for a total of 90 days. Treatment failure (required a nonstudy anticoagulant; had proximal deep vein thrombosis or …
Authors
Kearon C; Carrier M; Gu C-S; Schulman S; Bates S; Kahn S; Chagnon I; Nguyen D; Wu C; Rudd-Scott L
Journal
Seminars in Thrombosis and Hemostasis, Vol. 46, No. 08, pp. 977–985
Publisher
Thieme
Publication Date
November 2020
DOI
10.1055/s-0040-1718891
ISSN
0094-6176